15 September 2015 - Deborah Wilkes
Archived
Changing the behaviour of key stakeholders – including consumers, healthcare professionals and regulators – lies at the heart of any successful switch of a medicine from prescription to non-prescription status. Companies should also be prepared to rethink their own behaviour and expectations.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.